GLP-1 Therapies: A Potential Link to Reduced Autoimmune Complications
New research suggests GLP-1 therapies, known for treating obesity, may also be linked to fewer complications in adults with co-occurring autoimmune diseases.
-
-
Systemic Sclerosis: Unpacking Risks and Emerging Therapeutic Avenues
New insights are shedding light on the complex risks and promising treatment targets in systemic sclerosis, a challenging autoimmune connective tissue disease.
